Business
Currency:USD
2024/Q3
Stock NameRevenueRatio
Therapeutics3.7M85.16%
Contract research3.68M84.68%
Corporate and Other-3.04M-69.83%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States31.25M100.00%